1. Home
  2. RDY vs TBBK Comparison

RDY vs TBBK Comparison

Compare RDY & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • TBBK
  • Stock Information
  • Founded
  • RDY 1984
  • TBBK 1999
  • Country
  • RDY India
  • TBBK United States
  • Employees
  • RDY N/A
  • TBBK N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • TBBK Major Banks
  • Sector
  • RDY Health Care
  • TBBK Finance
  • Exchange
  • RDY Nasdaq
  • TBBK Nasdaq
  • Market Cap
  • RDY 2.5B
  • TBBK 2.6B
  • IPO Year
  • RDY N/A
  • TBBK 2004
  • Fundamental
  • Price
  • RDY $13.35
  • TBBK $56.13
  • Analyst Decision
  • RDY Buy
  • TBBK Buy
  • Analyst Count
  • RDY 1
  • TBBK 3
  • Target Price
  • RDY $17.00
  • TBBK $67.67
  • AVG Volume (30 Days)
  • RDY 1.8M
  • TBBK 535.7K
  • Earning Date
  • RDY 01-23-2025
  • TBBK 01-30-2025
  • Dividend Yield
  • RDY 3.60%
  • TBBK N/A
  • EPS Growth
  • RDY 2.68
  • TBBK 22.92
  • EPS
  • RDY 0.75
  • TBBK 4.29
  • Revenue
  • RDY $3,637,607,642.00
  • TBBK $495,381,000.00
  • Revenue This Year
  • RDY $17.23
  • TBBK N/A
  • Revenue Next Year
  • RDY $9.20
  • TBBK $8.21
  • P/E Ratio
  • RDY $17.68
  • TBBK $13.59
  • Revenue Growth
  • RDY 14.74
  • TBBK 10.62
  • 52 Week Low
  • RDY $13.16
  • TBBK $29.92
  • 52 Week High
  • RDY $16.89
  • TBBK $65.84
  • Technical
  • Relative Strength Index (RSI)
  • RDY 33.41
  • TBBK 41.30
  • Support Level
  • RDY $13.16
  • TBBK $59.57
  • Resistance Level
  • RDY $13.46
  • TBBK $62.56
  • Average True Range (ATR)
  • RDY 0.15
  • TBBK 2.27
  • MACD
  • RDY -0.01
  • TBBK -0.62
  • Stochastic Oscillator
  • RDY 21.02
  • TBBK 2.71

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.

Share on Social Networks: